GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,019,677 | -3.5% | 37,696 | +5.7% | 0.03% | -10.0% |
| Q3 2023 | $1,056,785 | -34.8% | 35,654 | -21.3% | 0.03% | -25.0% |
| Q2 2023 | $1,621,310 | +45.4% | 45,288 | -4.8% | 0.04% | +29.0% |
| Q1 2023 | $1,114,970 | +38.8% | 47,567 | +61.1% | 0.03% | +34.8% |
| Q4 2022 | $803,134 | -48.2% | 29,527 | +2.5% | 0.02% | -54.9% |
| Q3 2022 | $1,550,000 | -8.9% | 28,800 | -31.7% | 0.05% | +4.1% |
| Q2 2022 | $1,701,000 | -27.3% | 42,164 | +19.3% | 0.05% | +4.3% |
| Q1 2022 | $2,341,000 | -19.3% | 35,344 | +21.8% | 0.05% | -16.1% |
| Q4 2021 | $2,902,000 | +16022.2% | 29,017 | +24490.7% | 0.06% | +5500.0% |
| Q1 2021 | $18,000 | -45.5% | 118 | -53.9% | 0.00% | -50.0% |
| Q4 2020 | $33,000 | +560.0% | 256 | +422.4% | 0.00% | – |
| Q3 2020 | $5,000 | +150.0% | 49 | +145.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |